Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MAGTEST

Financiado

Cerrado

MAGTEST Simple and specific next generation lab on a chip in vitro molecular di...

MAGTEST Simple and specific next generation lab on a chip in vitro molecular diagnostic device Antimicrobial resistances are a clear and present danger for human health. More than ever, it is fundamental to have an accurate and fast bacteria identification tool to ensure the judicious deployment of antibiotics. Current dia... ver más

31/01/2017

MAGNOMICS SA

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

MAGNOMICS SA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2017-01-31

SMEInst-07-2016-2017: Stimulating the innovation potentia...

I+D

Cerrada hace 8 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

MAGNOMICS SA

50.00K€ | Lider

Proyectos interesantes

Biotrack-MED

Medical Technol...

Data Science

71K€ Cerrado

C4L

Medical Technol...

Data Science

4M€ Cerrado

AntibioDx

Medical Technol...

Data Science

71K€ Cerrado

PLEC2021-007972

Medical Technol...

Data Science

200K€ Cerrado

Molecular Culture

Medical Technol...

Data Science

5M€ Cerrado

ResisTEST

Medical Technol...

Data Science

150K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 6 meses Fecha Inicio: 2016-07-15
Fecha Fin: 2017-01-31

Líder del proyecto

MAGNOMICS SA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Antimicrobial resistances are a clear and present danger for human health. More than ever, it is fundamental to have an accurate and fast bacteria identification tool to ensure the judicious deployment of antibiotics. Current diagnostic solutions are either too complex and bulky to operate on site, or are simply not informative enough. Magnomics novel, fast, award winning proprietary technology is able to detect bacterial DNA using a simple, compact platform. This fully portable, easy to use in-vitro molecular diagnostic device addresses the concerns expressed by the European Commission with regards to antimicrobial resistances: it allows for the easy and convenient detection of bacteria in any substrate, significantly reducing the lead time for treatments. In line with the expected impact of the SMEInst-07-2016-2017 topic, Magnomics will initially focus on animal health diagnostics. This choice of market, worth €2.6bn in 2013 with an 8% growth estimated till 2018, was fully validated after winning the Innovation Award at the Kansas City Animal Health Investment Forum in 2015. Addressing a devastating disease in dairy farms across the world that is crushing the margins of milk producers in the EU, the first product will target bovine mastitis, an infection of the mammary gland of dairy cows with an annual economic impact of over €2bn in the EU alone. This technology is expected to significantly boost the competitiveness of the dairy industry through the reduction of health-related hindrances to production. In parallel, the milk production businesses will become more sustainable through the introduction of a high-end biotechnology process within their industrial pipeline, ensuring the efficient use of resources. MAGTEST will allow the company to fully assess the market potential, IPR status of Magnomics’ technology, ensuring an effective industrialization and commercialization strategy.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores